Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.

Smith TG, Ellison JA, Ma X, Kuzmina N, Carson WC, Rupprecht CE.

Vaccine. 2013 Jul 18;31(33):3333-8. doi: 10.1016/j.vaccine.2013.05.081. Epub 2013 Jun 3.

2.

A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.

Koraka P, Bosch BJ, Cox M, Chubet R, Amerongen Gv, Lövgren-Bengtsson K, Martina BE, Roose J, Rottier PJ, Osterhaus AD.

Vaccine. 2014 Aug 6;32(36):4644-50. doi: 10.1016/j.vaccine.2014.06.058. Epub 2014 Jun 21.

PMID:
24962755
3.

Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.

Um J, Chun BC, Lee YS, Hwang KJ, Yang DK, Park JS, Kim SY.

PLoS Negl Trop Dis. 2017 Dec 21;11(12):e0006084. doi: 10.1371/journal.pntd.0006084. eCollection 2017 Dec.

4.

Rhabdovirus-based vaccine platforms against henipaviruses.

Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ.

J Virol. 2015 Jan;89(1):144-54. doi: 10.1128/JVI.02308-14. Epub 2014 Oct 15.

5.

A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.

Nagarajan T, Reddy GS, Mohana Subramanian B, Rajalakshmi S, Thiagarajan D, Tordo N, Jallet C, Srinivasan VA.

Biologicals. 2006 Mar;34(1):21-7. Epub 2005 Sep 26.

PMID:
16188454
6.

Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.

Kang H, Qi Y, Wang H, Zheng X, Gao Y, Li N, Yang S, Xia X.

Viruses. 2015 Mar 11;7(3):1134-52. doi: 10.3390/v7031134.

7.

Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.

Ramya R, Mohana Subramanian B, Sivakumar V, Senthilkumar RL, Sambasiva Rao KR, Srinivasan VA.

Clin Vaccine Immunol. 2011 Oct;18(10):1673-9. doi: 10.1128/CVI.05258-11. Epub 2011 Aug 3.

8.

A thermostable messenger RNA based vaccine against rabies.

Stitz L, Vogel A, Schnee M, Voss D, Rauch S, Mutzke T, Ketterer T, Kramps T, Petsch B.

PLoS Negl Trop Dis. 2017 Dec 7;11(12):e0006108. doi: 10.1371/journal.pntd.0006108. eCollection 2017 Dec.

9.

Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.

Luo J, Shi H, Tan Y, Niu X, Long T, Zhao J, Tian Q, Wang Y, Chen H, Guo X.

Vaccine. 2016 Aug 17;34(37):4392-8. doi: 10.1016/j.vaccine.2016.07.020. Epub 2016 Jul 19.

PMID:
27449079
10.

Investigating the role for IL-21 in rabies virus vaccine-induced immunity.

Dorfmeier CL, Tzvetkov EP, Gatt A, McGettigan JP.

PLoS Negl Trop Dis. 2013;7(3):e2129. doi: 10.1371/journal.pntd.0002129. Epub 2013 Mar 14.

11.

Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.

Martins M, Joshi LR, Rodrigues FS, Anziliero D, Frandoloso R, Kutish GF, Rock DL, Weiblen R, Flores EF, Diel DG.

Virology. 2017 Nov;511:229-239. doi: 10.1016/j.virol.2017.08.027. Epub 2017 Sep 9.

PMID:
28898730
12.
13.

APRIL:TACI axis is dispensable for the immune response to rabies vaccination.

Haley SL, Tzvetkov EP, Lytle AG, Alugupalli KR, Plummer JR, McGettigan JP.

Antiviral Res. 2017 Aug;144:130-137. doi: 10.1016/j.antiviral.2017.06.004. Epub 2017 Jun 12.

PMID:
28619678
14.

G-protein based ELISA as a potency test for rabies vaccines.

Chabaud-Riou M, Moreno N, Guinchard F, Nicolai MC, Niogret-Siohan E, Sève N, Manin C, Guinet-Morlot F, Riou P.

Biologicals. 2017 Mar;46:124-129. doi: 10.1016/j.biologicals.2017.02.002. Epub 2017 Feb 14.

15.

Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.

Papaneri AB, Wirblich C, Marissen WE, Schnell MJ.

Vaccine. 2013 Dec 2;31(49):5897-902. doi: 10.1016/j.vaccine.2013.09.038. Epub 2013 Oct 10.

PMID:
24120673
16.

Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs.

McGettigan JP, David F, Figueiredo MD, Minke J, Mebatsion T, Schnell MJ.

Vaccine. 2014 Mar 26;32(15):1716-9. doi: 10.1016/j.vaccine.2014.01.043. Epub 2014 Feb 7.

17.

ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.

Norton JE Jr, Lytle AG, Shen S, Tzvetkov EP, Dorfmeier CL, McGettigan JP.

PLoS One. 2014 Jan 29;9(1):e87098. doi: 10.1371/journal.pone.0087098. eCollection 2014.

18.

A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.

Borhani K, Ajorloo M, Bamdad T, Mozhgani SH, Ghaderi M, Gholami AR.

Arch Iran Med. 2015 Apr;18(4):223-7. doi: 015184/AIM.006.

20.

A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.

Krämer B, Kamphuis E, Hanschmann KM, Milne C, Daas A, Duchow K.

Biologicals. 2013 Nov;41(6):400-6. doi: 10.1016/j.biologicals.2013.08.003. Epub 2013 Oct 18.

PMID:
24144483

Supplemental Content

Support Center